Stroke Severity in Patients on Non-Vitamin K Antagonist Oral Anticoagulants with a Standard or Insufficient Dose
- 문서 유형
- 연구출판물 · 학술지 논문
- 등재
- SCIEScopus
- 저널 순위
- JCR Q1Scopus Q1
- 저널
- THROMBOSIS AND HAEMOSTASIS118(12) · pp.2145 · 2018
- 피인용
- Web of Science 15Scopus 14
- FWCI (Scopus)
- 0.38
- JCR IF
- JCR 2017 4.952
- ISSN
- 0340-6245
저자
- Jung, Yo Han제1저자Department of Neurology, Changwon Fatima Hospital, Changwon, South Korea
- Choi, Hye-YeonDepartment of Neurology, Kyung Hee University, School of Medicine, Kyung Hee University Hospital at Gangdong, Seoul, South Korea
- Lee, Kyung-YulDepartment of Neurology, Gangnam Severance Hospital, Severance Institute for Vascular and Metabolic Research, Yonsei University, College of Medicine, Seoul, South Korea
- Cheon, KyeongyeolDepartment of Neurology, Gangnam Severance Hospital, Severance Institute for Vascular and Metabolic Research, Yonsei University, College of Medicine, Seoul, South Korea
- Han, Sang WonDepartment of Neurology, Sanggye Paik Hospital, Inje University, College of Medicine, Seoul, South Korea
- Park, Joong HyunDepartment of Neurology, Sanggye Paik Hospital, Inje University, College of Medicine, Seoul, South Korea
- 조한진Department of Neurology, Pusan National University Hospital, Pusan National University, College of Medicine, Biomedical Research Institute, Busan, South Korea
- Park, Hyung JongDepartment of Neurology, Yonsei University, College of Medicine, Seoul, South Korea
- Nam, Hyo SukDepartment of Neurology, Yonsei University, College of Medicine, Seoul, South Korea
- Heo, Ji HoeDepartment of Neurology, Yonsei University, College of Medicine, Seoul, South Korea
- Lee, Hye SunBiostatistics Collaboration Unit, Yonsei University, College of Medicine, Seoul, South Korea
- Kim, Young Dae교신저자Department of Neurology, Yonsei University, College of Medicine, Seoul, South Korea
초록
Background The stroke severity or functional outcomes could differ because the efficacy of non-vitamin K antagonist oral anticoagulants (NOACs) could be different according to the dose. We investigated whether there was any difference in the stroke outcomes in patients with non-valvular atrial fibrillation (NVAF) by their prior medication status, including standard-dosed versus under-dosed NOACs. Materials and Methods We enrolled 858 patients with acute ischaemic stroke with chronic NVAF admitted at six hospitals in Korea. We categorized their prior medication status as follows: (1) no anti-thrombotics (n = 219), (2) only anti-platelet (n = 347), (3) warfarin with a sub-therapeutic intensity (n = 185), (4) warfarin with a therapeutic intensity (n = 37), (5) under-dosed NOAC (n = 27) and (6) standard-dosed NOAC (n = 43). We compared the initial stroke severity between groups. Results Among the 858 patients, the patients on standard-dosed NOACs had the lowest initial National Institute of Health Stroke Scale (NIHSS) score, followed by those on warfarin with a therapeutic intensity and those on only anti-platelet (p < 0.05). Multivariate analysis demonstrated that the NIHSS score was significantly low in the patients on warfarin with a therapeutic intensity (B, -5.602; 95% confidence interval [CI], -8.636 to -2.568; p < 0.001) or those on standard-dosed NOACs (B, -3.588; 95% CI, -6.405 to -0.771; p = 0.013), while there was no difference in the NIHSS score between the patients not taking any anti-thrombotics and those on warfarin with a subtherapeutic intensity or under-dosed NOACs. Conclusion Use of warfarin with a therapeutic intensity or standard-dosed NOACs was associated with a relatively mild stroke in the patients with NVAF.
키워드
strokeatrial fibrillationoutcomeNOACACUTE ISCHEMIC-STROKEPARTIAL THROMBOPLASTIN TIMEATRIAL-FIBRILLATIONASIAN PATIENTSANTITHROMBOTIC TREATMENTWARFARINPREVENTIONDABIGATRAN
식별자
- Scopus EID
- 2-s2.0-85057756146
- WoS UID
- 000451853100015



로그인
연구물 목록으로